MX2011007639A - Carboxamide compounds and methods for using the same. - Google Patents

Carboxamide compounds and methods for using the same.

Info

Publication number
MX2011007639A
MX2011007639A MX2011007639A MX2011007639A MX2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A
Authority
MX
Mexico
Prior art keywords
methods
carboxamide compounds
same
compound
disclosed
Prior art date
Application number
MX2011007639A
Other languages
Spanish (es)
Inventor
Rajinder Singh
Hui Hong
Xiang Xu
Ihab S Darwish
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of MX2011007639A publication Critical patent/MX2011007639A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Abstract

Disclosed are carboxamide compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure (I) in which R1, R2, R3, R4, T, p, q, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
MX2011007639A 2009-01-28 2010-01-28 Carboxamide compounds and methods for using the same. MX2011007639A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14798209P 2009-01-28 2009-01-28
PCT/US2010/022411 WO2010088392A1 (en) 2009-01-28 2010-01-28 Carboxamide compounds and methods for using the same

Publications (1)

Publication Number Publication Date
MX2011007639A true MX2011007639A (en) 2011-09-15

Family

ID=42061132

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007639A MX2011007639A (en) 2009-01-28 2010-01-28 Carboxamide compounds and methods for using the same.

Country Status (18)

Country Link
US (2) US8362235B2 (en)
EP (1) EP2391616B1 (en)
JP (1) JP5658688B2 (en)
KR (1) KR101693061B1 (en)
CN (1) CN102365275B (en)
AU (1) AU2010208247B2 (en)
BR (1) BRPI1007287B8 (en)
CA (1) CA2750835C (en)
EA (1) EA022083B1 (en)
ES (1) ES2581678T3 (en)
HK (1) HK1164860A1 (en)
IL (1) IL214203A (en)
MX (1) MX2011007639A (en)
NZ (1) NZ594556A (en)
SG (1) SG172974A1 (en)
UA (1) UA106600C2 (en)
WO (1) WO2010088392A1 (en)
ZA (1) ZA201105215B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5658138B2 (en) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド Carboxamide compounds for the treatment of metabolic disorders
US8796254B2 (en) 2010-03-31 2014-08-05 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds
AU2011283684B2 (en) 2010-07-29 2015-08-27 Rigel Pharmaceuticals, Inc. AMPK-activating heterocyclic compounds and methods for using the same
US9005909B2 (en) 2011-01-06 2015-04-14 Rigel Pharmaceuticals, Inc. Whole blood assay for measuring AMPK activation
WO2013116491A1 (en) 2012-02-01 2013-08-08 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds and methods for using them
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6064062B2 (en) 2013-03-15 2017-01-18 ファイザー・インク Indazole compounds that activate AMPK
US20150087673A1 (en) * 2013-09-26 2015-03-26 Rigel Pharmaceuticals, Inc. Methods for using and biomarkers for ampk-activating compounds
JP6664632B2 (en) 2013-09-30 2020-03-13 国立大学法人 東京大学 Adiponectin receptor activating compound
KR20200119807A (en) 2018-01-11 2020-10-20 켄타우루스 테라퓨틱스 Inhibitors of dihydroceramide desaturase for disease treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
KR100579792B1 (en) * 1998-05-13 2006-05-12 동화약품공업주식회사 Novel 2,5-pyridinedicarboxylic acid derivatives
JP2004509891A (en) * 2000-09-22 2004-04-02 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Pyrazolopyridine and pyrazolopyridazine as antidiabetic drugs
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
JP2009521445A (en) * 2005-12-21 2009-06-04 シェーリング コーポレイション Combination of H3 antagonist / inverse agonist and appetite suppressant
EP1932834B1 (en) 2006-12-11 2011-04-27 The Genetics Company, Inc. Aromatic 1,4-DI-Carboxylamides and their use
CA2674237C (en) 2006-12-28 2015-11-24 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
GB0706793D0 (en) * 2007-04-05 2007-05-16 Evotec Ag Compounds
CN101910131B (en) 2007-11-16 2014-04-23 里格尔药品股份有限公司 Carboxamide, sulfonamide and amine compounds and usagmethod thereof
WO2009076631A1 (en) * 2007-12-12 2009-06-18 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
JP5658138B2 (en) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド Carboxamide compounds for the treatment of metabolic disorders
US8796254B2 (en) 2010-03-31 2014-08-05 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds

Also Published As

Publication number Publication date
US8846600B2 (en) 2014-09-30
WO2010088392A1 (en) 2010-08-05
CN102365275B (en) 2014-09-24
BRPI1007287B8 (en) 2021-05-25
CA2750835A1 (en) 2010-08-05
IL214203A (en) 2015-01-29
EA022083B1 (en) 2015-10-30
SG172974A1 (en) 2011-08-29
EA201170979A1 (en) 2012-02-28
JP5658688B2 (en) 2015-01-28
JP2012516349A (en) 2012-07-19
IL214203A0 (en) 2011-08-31
AU2010208247B2 (en) 2015-06-18
ES2581678T3 (en) 2016-09-06
ZA201105215B (en) 2012-09-26
AU2010208247A1 (en) 2011-08-11
EP2391616A1 (en) 2011-12-07
US8362235B2 (en) 2013-01-29
CA2750835C (en) 2018-09-04
US20100190802A1 (en) 2010-07-29
NZ594556A (en) 2013-11-29
KR20110119755A (en) 2011-11-02
US20130131078A1 (en) 2013-05-23
BRPI1007287B1 (en) 2021-03-09
EP2391616B1 (en) 2016-03-30
HK1164860A1 (en) 2012-09-28
UA106600C2 (en) 2014-09-25
KR101693061B1 (en) 2017-01-04
CN102365275A (en) 2012-02-29

Similar Documents

Publication Publication Date Title
MX2010005298A (en) Carboxamide, sulfonamide and amine compounds for metabolic disorders.
MX2011007639A (en) Carboxamide compounds and methods for using the same.
MX338707B (en) Ampk-activating heterocyclic compounds and methods for using the same.
MX336381B (en) Boronates as arginase inhibitors.
BRPI0910182B8 (en) compound of formula (I), pharmaceutical composition and use of a compound
MA33776B1 (en) Derivatives of arylcarbonyl and non-aryl carbonyl
MA32393B1 (en) Compounds and compounds that act as kinase inhibitors
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
EA201100503A1 (en) GLUCOSIDE DERIVATIVES AND THEIR APPLICATIONS
GB0625648D0 (en) Compounds
JO3025B1 (en) Oxazole substituted indazoles as pi3 - kinase inhibitors
UA108743C2 (en) HINAZOLINE-4 (3H) -ONE DERIVATIVES FOR APPLICATION AS RI-KINASE INHIBITORS
EA201071231A1 (en) CARBOXAMIDE CONNECTIONS FOR THE TREATMENT OF METABOLIC DEVICES
GEP20227397B (en) Inhibitors of influenza viruses replication
MX2011011854A (en) Dihydropyrimidinones for use as bace2 inhibitors.
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
UA109037C2 (en) Triazolepyridins
MA32544B1 (en) Derivatives of pyridino pyridinone - their preparation and application in treatment
EA201070327A1 (en) CATECHOLAMINE DERIVATIVES AND THEIR DEVICES
MX2011013884A (en) Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof.
TN2013000529A1 (en) Trpm8 antagonists and their use in treatments
JO2682B1 (en) 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof
MX2011008360A (en) Heteroaryl substituted pyridazinone derivatives.
MX2010004498A (en) Cyclohexeneamide derivatives and their use as trpv1 antagonist.

Legal Events

Date Code Title Description
FG Grant or registration